Novartis - Quarterly Results
11th Nov 2021

The Revenue for the quarter ended  September 2021 of Rs. 1044.80 millions grew by 9.03 % from Rs. 958.30 millions.Net profit declined -6.65% to Rs. 70.20 millions from Rs. 75.20 millions.A decline of 134.70 millions was observed in the OP in the quarter ended September 2021 from 158.10 millions on QoQ basis.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1044.80 958.30 9.03 2025.90 1882.90 7.59 3813.50 4382.50 -12.98
Other Income 63.80 56.00 13.93 128.40 125.60 2.23 330.90 361.40 -8.44
PBIDT 134.70 158.10 -14.80 277.70 269.60 3.00 598.80 481.70 24.31
Interest 15.00 16.60 -9.64 30.40 33.40 -8.98 76.80 63.90 20.19
PBDT 119.70 141.50 -15.41 247.30 236.20 4.70 522.00 417.80 24.94
Depreciation 26.80 31.00 -13.55 55.90 61.60 -9.25 121.60 131.40 -7.46
PBT 92.90 110.50 -15.93 191.40 174.60 9.62 400.40 286.40 39.80
TAX 22.70 35.30 -35.69 58.40 55.50 5.23 191.40 185.60 3.13
Deferred Tax -6.60 -7.60 -13.16 -12.70 -10.00 27.00 -34.80 33.40 -204.19
PAT 70.20 75.20 -6.65 133.00 119.10 11.67 209.00 100.80 107.34
Equity 123.40 123.40 0.00 123.40 123.40 0.00 123.40 123.40 0.00
PBIDTM(%) 12.89 16.50 -21.85 13.71 14.32 -4.27 15.70 10.99 42.86